In vitro interaction of recombinant tumor necrosis factor alpha and all-trans-retinoic acid with normal and leukemic hematopoietic cells.

Both human recombinant tumor necrosis factor alpha (TNF alpha) and all-trans-retinoic acid (RA) inhibit the in vitro clonal growth of human myeloid leukemic cells. We investigated the in vitro interaction of TNF alpha and RA with normal and a variety of leukemic myeloid cells. With the promyelocytic HL-60 cells, TNF alpha (greater than or equal to 2.5 U/mL) in combination with RA synergistically inhibited clonal growth; TNF alpha at lower concentrations (less than or equal to 1 U/mL) plus RA (10(-9) mol/L) were antagonistic in their inhibition of growth. The ability of RA (10(-8) mol/L) plus TNF alpha (2.5, 5 U/mL) to enhance differentiation of HL-60 cells paralleled their ability to inhibit clonal growth of these cells. In addition, RA (10(-9) to 10(-7) mol/L) increased the number of TNF alpha receptors on HL-60 cells 1.3- to 1.7-fold without changing the affinity for the TNF alpha receptor. With the more immature KG-1 myeloblasts, concentrations of TNF alpha greater than 10 U/mL synergistically interacted with RA to inhibit clonal growth; at lower concentrations of TNF alpha (less than 10 U/mL), RA appeared to inhibit the expected effect of TNF alpha. KG-1 cells were not induced to differentiate with either agent alone or in combination. With four of nine leukemic patients, TNF alpha in combination with RA (10(-7) mol/L) inhibited leukemic clonal growth to a greater extent than each agent alone. No marked effect of the combined treatment was seen in two other patients. The RA reversed the inhibitory action of TNF alpha on normal human granulocyte-macrophage colony forming cells (GM-CFC) and on clonal growth of leukemic cells from three patients. Our study suggests that TNF alpha and RA interact in a complex manner with normal and leukemic hematopoietic cells.

[1]  J. Dipersio,et al.  Tumor necrosis factor: receptors on hematopoietic cells. , 1987, Blood.

[2]  M. Rosenblum,et al.  Phase I study of recombinant tumor necrosis factor in cancer patients. , 1987, Cancer research.

[3]  R. Clark,et al.  EFFECT OF 13-cis-RETINOIC ACID ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME , 1987, The Lancet.

[4]  P. Koeffler,et al.  In vitro action of tumor necrosis factor on myeloid leukemia cells. , 1987, Blood.

[5]  G. Trinchieri,et al.  Retinoic acid cooperates with tumor necrosis factor and immune interferon in inducing differentiation and growth inhibition of the human promyelocytic leukemic cell line HL-60. , 1987, Blood.

[6]  J. Gutterman,et al.  Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines , 1987 .

[7]  R. Ohno,et al.  Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells. , 1987, Blood.

[8]  U. Gullberg,et al.  Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor. , 1986, The Journal of clinical investigation.

[9]  R. I. Glazer,et al.  Appearance of membrane-bound tyrosine kinase during differentiation of HL-60 leukemia cells by immune interferon and tumor necrosis factor. , 1986, Biochemical and biophysical research communications.

[10]  G. Trinchieri,et al.  Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon , 1986, The Journal of experimental medicine.

[11]  P. Scheurich,et al.  Quantification and characterization of high‐affinity membrane receptors for tumor necrosis factor on human leukemic cell lines , 1986, International journal of cancer.

[12]  A. Tobler,et al.  Retinoids. Structure-function relationship in normal and leukemic hematopoiesis in vitro. , 1986, The Journal of clinical investigation.

[13]  D. Williams,et al.  The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. , 1986, Journal of immunology.

[14]  P. Nowell,et al.  Disappearance of cytogenetic abnormalities and clinical remission during therapy with 13-cis-retinoic acid in a patient with myelodysplastic syndrome: inhibition of growth of the patient's malignant monocytoid clone. , 1986, Blood.

[15]  F. Hecht,et al.  13-cis retinoic acid treatment for myelodysplastic syndromes. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Vilček,et al.  Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. , 1986, Journal of immunology.

[17]  E. Vellenga,et al.  Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia. , 1986, Blood.

[18]  J. Fontana,et al.  The role of 13 cis‐retinoic acid in the remission induction of a patient with acute promyelocytic leukemia , 1986, Cancer.

[19]  K. Takeda,et al.  Identity of differentiation inducing factor and tumour necrosis factor , 1986, Nature.

[20]  T. C. Barnett,et al.  Phase I-II study of 13-cis-retinoic acid in myelodysplastic syndrome. , 1985, Cancer treatment reports.

[21]  B. Aggarwal,et al.  Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon , 1985, Nature.

[22]  B. Aggarwal,et al.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.

[23]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[24]  E. R. Christensen,et al.  A general noninteractive multiple toxicity model including probit, logit, and Weibull transformations. , 1985, Biometrics.

[25]  D. Goeddel,et al.  Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Strickler,et al.  Molecular cloning of the complementary DNA for human tumor necrosis factor. , 1985, Science.

[27]  W. Piacibello,et al.  In-vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis. , 1985, Leukemia research.

[28]  T. Shirai,et al.  Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor , 1985, Nature.

[29]  H. Findley,et al.  Effect of retinoic acid on the clonal growth of childhood myeloid and lymphoid leukemias: a pediatric oncology group study. , 1984, Experimental hematology.

[30]  B. Nilsson.  Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia , 1984, British journal of haematology.

[31]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.

[32]  R. Branda,et al.  Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. , 1983, Blood.

[33]  R. Mertelsmann,et al.  Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. , 1983, Cancer treatment reports.

[34]  M. Sporn,et al.  Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. , 1983, Cancer research.

[35]  H. Koeffler,et al.  Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. , 1982, Experimental cell research.

[36]  H. Koeffler,et al.  Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. , 1982, The Journal of clinical investigation.

[37]  S. Collins,et al.  Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid , 1981 .

[38]  S. Collins,et al.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Golde,et al.  Human T lymphocyte cell line producing colony-stimulating activity. , 1978, Blood.

[40]  H. Koeffler,et al.  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. , 1978, Science.

[41]  S. Collins,et al.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture , 1977, Nature.

[42]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Calyampudi R. Rao,et al.  Linear Statistical Inference and Its Applications. , 1975 .